Related Experiment Video
Updated: Dec 25, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
miR-335 Acts as a Tumor Suppressor and Enhances Ionizing Radiation-Induced Tumor Regression by Targeting ROCK1
1Department of Dermatology, Shengjing Hospital of China Medical University, Shenyang, China.
Abstract:
Recent development of integrative therapy against melanoma combines surgery, radiotherapy, targeted therapy, and immunotherapy; however, the clinical outcomes of advanced stage and recurrent melanoma are poor. As a skin cancer, melanoma is generally resistant to radiotherapy. Hence, there is an urgent need for evaluation of the mechanisms of radioresistance. The present study identified miR-335 as one of the differential expression of miRNAs in recurrent melanoma biopsies post-radiotherapy. The expression of miR-335 declined in melanoma tissues compared to the adjacent tissues. Moreover, miR-335 expression correlated with advanced stages of melanoma negatively. Consistent with the prediction of STARBASE and miRDB database, miR-335 targeted ROCK1 via binding with 3'-UTR of ROCK1 directly, resulting in attenuation of proliferation, migration, and radioresistance of melanoma cells. The authors validated that overexpression of miR-335 enhanced X-ray-induced tumor regression by B16 mouse models. Briefly, the present findings gained insights into miR-335/ROCK1-mediated radiosensitivity and provided a promising therapeutic strategy for improving radiotherapy against melanoma.
Insights
MicroRNA-335 (miR-335) may overcome melanoma radioresistance. Lower miR-335 levels correlate with advanced melanoma, and its restoration can enhance radiotherapy effectiveness against skin cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Melanoma, a skin cancer, exhibits poor outcomes with advanced or recurrent disease, often showing resistance to radiotherapy.
- Current integrative therapies for melanoma have limitations, necessitating research into radioresistance mechanisms.
Purpose of the Study:
- To investigate the role of microRNAs (miRNAs) in melanoma radioresistance.
- To identify specific miRNAs involved in recurrent melanoma post-radiotherapy and elucidate their therapeutic potential.
Main Methods:
- Differential expression analysis of miRNAs in melanoma tissues.
- Bioinformatic prediction and experimental validation of miRNA targets.
- In vitro assays assessing cell proliferation, migration, and radioresistance.
- In vivo studies using mouse models to evaluate tumor regression.
Main Results:
- miR-335 expression was significantly decreased in melanoma tissues and correlated negatively with advanced melanoma stages.
- miR-335 directly targets ROCK1, inhibiting melanoma cell proliferation, migration, and radioresistance.
- Overexpression of miR-335 enhanced X-ray-induced tumor regression in a mouse model.
Conclusions:
- miR-335 plays a crucial role in modulating melanoma radiosensitivity by targeting ROCK1.
- Restoring miR-335 levels presents a potential therapeutic strategy to improve radiotherapy outcomes for melanoma patients.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

